ClinicalTrialsFinder

Neuromyelitis Optica Spectrum Disorder Attack Clinical Trials in Tianjin, Tianjin Municipality

1 recruitingTianjin, Tianjin Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder

Neuromyelitis Optica Spectrum Disorder Attack
Tianjin Medical University General Hospital110 enrolled1 locationNCT07184840